Clinical case of surgical treatment of patient with toxic phosporus osteonecrosis of maxilla

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

During the last few years on the territory of the Russian Federation, the number of cases of toxic phosphoric osteonecrosis of the jaws illicit use of drugs of “artisanal” production (pervitin, desomorphin). The aim of our study was to increase the effectiveness of surgical treatment of a patient diagnosed of toxic phosphorus necrosis of the maxilla. We performed a comprehensive treatment of a patient with a history of drug addiction and the above diagnosis. We performed complete resection of pathologically altered tissues and reconstructive techniques using local tissues and a replaced flap. This achieves good esthetic and functional results in the early and late postoperative period. Thus, we can use our proposed method of surgical treatment in similar clinical situations.

作者简介

Yu. Medvedev

A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: dispiryan@gmail.com
俄罗斯联邦, Moscow

Davit Ispiryan

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

编辑信件的主要联系方式.
Email: dispiryan@gmail.com

post graduate student of Department of Maxillofacial Surgery of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

俄罗斯联邦, Moscow

I. Zakharova

Ryazan State Medical University

Email: dispiryan@gmail.com
俄罗斯联邦, Ryazan

P. Petruk

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

Email: dispiryan@gmail.com
俄罗斯联邦, Moscow

参考

  1. Adornato MC, Morcos I, Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc. 2007;138(7):971–7. doi: 10.14219/jada.archive.2007.0294.
  2. Basin EM, Medvedev YuA. Toxic phosphorus osteonecrosis of facial bones among drug addicts to desomorphine and pervitin. Part I. Stoma-tologiya. 2015;94(2):53–7. (in Russian) doi: 10.17116/stomat201594253–57.
  3. Marx RE, Sawatari Y, Fortin, M, Broumand V. Bisphosphonate induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recog-nition, prevention, and treatment. J Oral Maxillofac Surg. 2005;63(11):1567–75. doi: 10.1016/j.joms.2005.07.010.
  4. Coleman RE. Risks and benefits of bisphosphonates. Br J Cancer. 2008;98(11):1736–40. doi: 10.1038/sj.bjc.6604382.
  5. Dimopoulos M, Kastritis E, Moulopoulos LA, Melakopoulos I, Anagnostopoulos A, Gika D. et al. The incidence of osteonecrosis of the jaw in pa-tients with multiple myeloma who receive bisphosphonates depends on the type of bisphosphonate. Blood. 2005;106(11):637. doi: 10.1182/blood.v106.11.637.637.
  6. Eisele DW, Smith RV. Complications in head and neck surgery. 2nd ed. Philadelphia: Mosby, Elseiver; 2009.
  7. Medvedev YuA, Basin EM, Serova NS, Korshunova AV, Babkova AA, Kureshova DN. Total jaw osteonecrosis among drug addicts. Rossiyskiy stoma-tologicheskiy zhurnal. 2016;20(4):183–9. (in Russian) doi: 10.18821/1728–28022016;20(4)183–189.
  8. Malanchuk VA, Brodetskiy IS. Complex treatment of patients with osteomyelitis of the jaws on the background of drug addiction. Vestnik Vi-tebskogo gosudarstvennogo meditsinskogo universiteta. 2014;13(2):115–23. (in Russian)

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eco-Vector, 2020


 


##common.cookie##